FBRX

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Forte Biosciences Inc

NASDAQ | FBRX

14.75

USD

$0.00

(

0.00%

)

At Close (As of Oct 13, 2025)

$189.85M

Market Cap

-

P/E Ratio

-3.68

EPS

$28.68

52 Week High

$4.11

52 Week Low

HEALTHCARE

Sector

FBRX Chart

Recent Chart
Price Action

FBRX Technicals

Tags:

FBRX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$39K
Total Revenue $0
Cost Of Revenue $39K
Costof Goods And Services Sold $39K
Operating Income -$37M
Selling General And Administrative $15M
Research And Development $21M
Operating Expenses $37M
Investment Income Net -
Net Interest Income $1.3M
Interest Income $1.3M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $39K
Income Before Tax -$35M
Income Tax Expense -$35M
Interest And Debt Expense -
Net Income From Continuing Operations -$35M
Comprehensive Income Net Of Tax -
Ebit -$35M
Ebitda -$35M
Net Income -$35M

Revenue & Profitability

Earnings Performance

FBRX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $62M
Total Current Assets $61M
Cash And Cash Equivalents At Carrying Value $22M
Cash And Short Term Investments $22M
Inventory -
Current Net Receivables -
Total Non Current Assets $215K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $36M
Other Current Assets $3M
Other Non Current Assets -
Total Liabilities $9.1M
Total Current Liabilities $9.1M
Current Accounts Payable $4.9M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $4.2M
Other Non Current Liabilities -
Total Shareholder Equity $52M
Treasury Stock -
Retained Earnings -$154M
Common Stock $6K
Common Stock Shares Outstanding $2.9M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$31M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $39K
Capital Expenditures $37K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$36M
Cashflow From Financing $52M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$1K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$35M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$39K
Total Revenue $0
Cost Of Revenue $39K
Costof Goods And Services Sold $39K
Operating Income -$37M
Selling General And Administrative $15M
Research And Development $21M
Operating Expenses $37M
Investment Income Net -
Net Interest Income $1.3M
Interest Income $1.3M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $39K
Income Before Tax -$35M
Income Tax Expense -$35M
Interest And Debt Expense -
Net Income From Continuing Operations -$35M
Comprehensive Income Net Of Tax -
Ebit -$35M
Ebitda -$35M
Net Income -$35M

FBRX News

FBRX Profile

Forte Biosciences Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Forte Biosciences Inc. is a clinical-stage biopharmaceutical company based in Torrance, California, focused on developing innovative therapeutics for various skin diseases, with a specific emphasis on eczema and associated conditions. The company's proprietary platform leverages cutting-edge genetic and biological research to create targeted treatment solutions with the potential for improved patient outcomes. As Forte navigates the complexities of clinical trials and regulatory pathways, it positions itself as a key player in the evolving landscape of dermatological therapies, making it an attractive prospect for institutional investors interested in the biotech sector.

VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
BURU
+7.74%
$0.51
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
PLUG
+14.03%
$3.90
INTC
-3.78%
$36.36
RGTI
+25.02%
$54.91
GWH
+117.54%
$9.05
NVDA
+2.81%
$188.32
BITF
+28.33%
$5.39
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
JOBY
+3.00%
$16.77
DNN
+6.94%
$3.08
CAN
+39.44%
$1.52
GPUS
-12.48%
$0.42
QBTS
+22.83%
$40.56
SNAP
-7.15%
$7.78
TSLA
+5.41%
$435.90
BBD
+0.98%
$3.09
F
+1.18%
$11.54
CLF
+4.93%
$13.83
WULF
-0.58%
$13.51
AXDX
-61.36%
$0.03
NIO
+7.00%
$7.18
PFE
-1.82%
$24.78
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
CRML
+55.40%
$23.28
ETHD
-12.82%
$3.33
ACHR
+6.68%
$12.77
RXRX
+3.94%
$5.53
SOUN
+10.25%
$19.14
APLD
+0.73%
$34.24
TLRY
-1.74%
$1.69
BTBT
+6.38%
$4.00
DFLI
+44.03%
$1.57
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
NAK
+31.03%
$2.66
ONDS
+17.24%
$10.81
LAES
+13.30%
$6.13
DVLT
-10.52%
$1.70
CIFR
+19.77%
$20.32
RR
+8.95%
$6.45
MP
+21.34%
$95.06
USAR
+18.61%
$38.68
IREN
+7.31%
$64.14
ABAT
+36.59%
$9.22
NAKA
-1.56%
$0.85
RIG
+3.89%
$3.20
IONQ
+16.19%
$82.09
AAL
+1.90%
$11.74
QUBT
+12.85%
$21.46
NOK
-1.31%
$5.25
UUUU
+16.88%
$23.77
MARA
+8.52%
$20.23
UAMY
+36.85%
$16.71
EOSE
+23.37%
$17.05
PLTR
+1.00%
$177.21
BMNR
+8.34%
$56.85
RMBL
+60.50%
$3.21
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
XCH
+103.41%
$1.68
AAPL
+0.97%
$247.66
TMQ
-9.46%
$5.93
BULL
+2.98%
$11.74
T
-1.08%
$25.59
RF
+1.65%
$24.56
SRM
+53.27%
$10.30
BTG
+4.52%
$5.31
CLSK
+3.94%
$20.04
NB
+8.95%
$11.32
GDXD
-13.62%
$0.73
GOOGL
-2.05%
$236.57
QSI
+24.55%
$2.08
VALE
+2.37%
$11.00
SMR
+14.72%
$45.02
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ORCL
-1.34%
$292.95
ABEV
+1.42%
$2.14
BE
+26.54%
$109.93
WLGS
-5.57%
$0.04
RGTZ
-50.00%
$9.30
TMC
+20.31%
$10.69
HOOD
+1.23%
$140.68
KDLY
-7.21%
$0.87
ETWO
0.00%
$3.30
VZ
-0.27%
$39.74
OKLO
+16.20%
$171.00
RIOT
+3.28%
$21.70
PMAX
+44.78%
$3.75
VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
BURU
+7.74%
$0.51
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
PLUG
+14.03%
$3.90
INTC
-3.78%
$36.36
RGTI
+25.02%
$54.91
GWH
+117.54%
$9.05
NVDA
+2.81%
$188.32
BITF
+28.33%
$5.39
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
JOBY
+3.00%
$16.77
DNN
+6.94%
$3.08
CAN
+39.44%
$1.52
GPUS
-12.48%
$0.42
QBTS
+22.83%
$40.56
SNAP
-7.15%
$7.78
TSLA
+5.41%
$435.90
BBD
+0.98%
$3.09
F
+1.18%
$11.54
CLF
+4.93%
$13.83
WULF
-0.58%
$13.51
AXDX
-61.36%
$0.03
NIO
+7.00%
$7.18
PFE
-1.82%
$24.78
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
CRML
+55.40%
$23.28
ETHD
-12.82%
$3.33
ACHR
+6.68%
$12.77
RXRX
+3.94%
$5.53
SOUN
+10.25%
$19.14
APLD
+0.73%
$34.24
TLRY
-1.74%
$1.69
BTBT
+6.38%
$4.00
DFLI
+44.03%
$1.57
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
NAK
+31.03%
$2.66
ONDS
+17.24%
$10.81
LAES
+13.30%
$6.13
DVLT
-10.52%
$1.70
CIFR
+19.77%
$20.32
RR
+8.95%
$6.45
MP
+21.34%
$95.06
USAR
+18.61%
$38.68
IREN
+7.31%
$64.14
ABAT
+36.59%
$9.22
NAKA
-1.56%
$0.85
RIG
+3.89%
$3.20
IONQ
+16.19%
$82.09
AAL
+1.90%
$11.74
QUBT
+12.85%
$21.46
NOK
-1.31%
$5.25
UUUU
+16.88%
$23.77
MARA
+8.52%
$20.23
UAMY
+36.85%
$16.71
EOSE
+23.37%
$17.05
PLTR
+1.00%
$177.21
BMNR
+8.34%
$56.85
RMBL
+60.50%
$3.21
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
XCH
+103.41%
$1.68
AAPL
+0.97%
$247.66
TMQ
-9.46%
$5.93
BULL
+2.98%
$11.74
T
-1.08%
$25.59
RF
+1.65%
$24.56
SRM
+53.27%
$10.30
BTG
+4.52%
$5.31
CLSK
+3.94%
$20.04
NB
+8.95%
$11.32
GDXD
-13.62%
$0.73
GOOGL
-2.05%
$236.57
QSI
+24.55%
$2.08
VALE
+2.37%
$11.00
SMR
+14.72%
$45.02
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ORCL
-1.34%
$292.95
ABEV
+1.42%
$2.14
BE
+26.54%
$109.93
WLGS
-5.57%
$0.04
RGTZ
-50.00%
$9.30
TMC
+20.31%
$10.69
HOOD
+1.23%
$140.68
KDLY
-7.21%
$0.87
ETWO
0.00%
$3.30
VZ
-0.27%
$39.74
OKLO
+16.20%
$171.00
RIOT
+3.28%
$21.70
PMAX
+44.78%
$3.75
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.